To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?

Triple artemisinin-based combination therapies (TACTs) are being developed as a response to artemisinin and partner drug resistance in the treatment of falciparum malaria in Southeast Asia. In African countries, where current artemisinin-based combination therapies (ACTs) are still effective, TACTs...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2021-08, Vol.16 (8), p.e0256567-e0256567
Hauptverfasser:	de Haan, Freek, Bolarinwa, Oladimeji Akeem, Guissou, Rosemonde, Tou, Fatoumata, Tindana, Paulina, Boon, Wouter P C, Moors, Ellen H M, Cheah, Phaik Yeong, Dhorda, Mehul, Dondorp, Arjen M, Ouedraogo, Jean Bosco, Mokuolu, Olugbenga A, Amaratunga, Chanaki
Format:	Artikel
Sprache:	eng
Schlagworte:	Antimalarials - therapeutic use Artemisinin Artemisinins - therapeutic use Burkina Faso Channels Combination therapy Current distribution Data collection Drug Approval Drug resistance Drug Therapy, Combination Feasibility studies Focus Groups Health risks Health sciences Humans Innovations Interviews Malaria Malaria - drug therapy Marketing Medicine Medicine and Health Sciences Nigeria Patient Acceptance of Health Care Patients People and Places Practice Guidelines as Topic Prescription Drugs Prevention Private Sector Public Sector Qualitative research Risk reduction Social Control, Formal Social Sciences Sustainable development Vector-borne diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!